Concepedia

Thalidomide and celecoxib as potential modulators of irinotecan’s activity in cancer patients

Miguel A. Villalona‐Calero, Larry J. Schaaf, Gary Phillips, Gregory A. Otterson, Kevin Panico, Wenrui Duan, Barbara Kleiber, Manisha H. Shah, Donn C. Young, Wan-Hong Wu,

Cancer Chemotherapy and Pharmacology · 2006 · 10 citations · 27 references

DOI

Concepts

References

27

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

J-Y Douillard, David Cunningham, AD Roth et al. · The Lancet · 2000 · 3.3K citations

, , +13

An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

Amer A. Beg, David Baltimore · Science · 1996 · 3.1K citations

, , +17

NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation

Cun-Yu Wang, Marty W. Mayo, Robert G. Korneluk et al. · Science · 1998 · 2.7K citations · Full text

, , +17

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

Seema Singhal, Jayesh Mehta, Raman Desikan et al. · New England Journal of Medicine · 1999 · 2.6K citations · Full text

, , +14

Thalidomide is an inhibitor of angiogenesis.

Robert J. D’Amato, Michael Loughnan, Evelyn Flynn et al. · Proceedings of the National Academy of Sciences · 1994 · 2.5K citations

, , +14